Bio-Rad Laboratories (BIO-B) Free Cash Flow (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Free Cash Flow data on file, last reported at $78.1 million in Q1 2026.

• Free Cash Flow for Q1 2026 came in at $78.1 million, down 18.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $357.2 million (changed 0.48% YoY), and the FY2025 annual result was $374.6 million, up 29.35% from the prior year.
• Free Cash Flow declined to $78.1 million in Q1 2026 per BIO-B's latest filing, from $119.1 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $123.4 million in Q3 2024 and troughed at -$16.6 million in Q3 2022.
• A 5-year average of $61.3 million and a median of $62.4 million in 2023 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 108.47% in 2022, then surged 423.42% in 2023.
• A 5-year view of Free Cash Flow shows it stood at $44.8 million in 2022, then dropped by 13.52% to $38.7 million in 2023, then jumped by 109.87% to $81.3 million in 2024, then soared by 46.49% to $119.1 million in 2025, then tumbled by 34.42% to $78.1 million in 2026.
• Business Quant data shows BIO-B's Free Cash Flow at $78.1 million in Q1 2026, $119.1 million in Q4 2025, and $89.2 million in Q3 2025.